酸盐激酶M2是一种PHD3刺激的催氧诱导因子1的协活性剂
Weibo Luo1, Hongxia Hu, Ryan Chang
1Vascular Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Cell
|May 31, 2011
概括
酸激酶M2 (PKM2) 蛋白与缺氧诱导因子1 (HIF-1) 相互作用,增强癌细胞基因活性并改变葡萄糖代谢. 这种相互作用促进瘤生长,并为持续的癌细胞功能创造反循环.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 酸盐激酶M2 (PKM2) 是PKM2基因的替代拼接产物,与PKM1.1不同.
- PKM2通过其已知的酶活性之外的机制影响癌细胞葡萄糖代谢和瘤发生.
研究的目的:
- 研究PKM2在调节葡萄糖代谢和瘤发生中的作用.
- 阐明PKM2影响低氧诱导因子1 (HIF-1) 活性的分子机制.
主要方法:
- 通过HIF-1研究PKM2基因转录激活.
- 分析了PKM2与HIF-1α的相互作用及其对HIF-1基因交换激活的影响.
- 通过质谱和抗体测定,研究了prolyl氧酶3 (PHD3) 在PKM2功能中的作用.
- 评估了PHD3中断对细胞新陈代谢的影响.
主要成果:
- PKM2,而不是PKM1,与HIF-1α相互作用,增强HIF-1结合和p300招募,促进HIF-1基因的交换激活.
- 基基酶3 (PHD3) 增强了PKM2与HIF-1α的相互作用及其协激活器功能.
- PKM2在proline-403/408上化,而PHD3倒置会损害PKM2的协同激活器功能,减少葡萄糖吸收和乳酸盐生产,并增加氧气消耗.
- PKM2与HIF-1形成一个积极的反循环,重编程癌细胞中的葡萄糖代谢.
结论:
- 通过与HIF-1的相互作用,PKM2在调节癌细胞代谢和促进瘤发生方面发挥着至关重要的作用.
- PKM2-HIF-1相互作用代表了癌症中代谢重编程的新机制.
- 准PKM2-HIF-1通路可能为癌症治疗提供治疗策略.
相关概念视频
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...


